COLL2-1 PEPTIDE AND ITS NITRATED FORM AS THERAPEUTIC TARGETS FOR OSTEOARTHRITIS TREATMENT

• 收藏
• 分享

专利权人:

Université de Liège;Institut National de la Santé et de la Recherche Médicale;Université Paris Descartes;Assistance Publique Hopitaux de Paris

发明人:

Yves HENROTIN,Cécile LAMBERT,Didier BORDERIE,François RANNOU

申请号：

US15624801

公开号：

US20170320939A1

申请日:

2017.06.16

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The present invention provides a medicament comprising as active ingredient an inhibitor of Coll2-1 peptide activity and/or an inhibitor of Coll2-1NO2 peptide activity for use in the prevention and/or treatment of osteoarthritis. Further, the present invention provides a medicament comprising as active ingredient an inhibitor of Coll2-1 peptide activity and/or an inhibitor of Coll2-1NO2 peptide activity for use in the prevention and/or treatment of rheumatic and musculoskeletal diseases (RMDs).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/